50/120
2.1 / 5 stars
All 120 Win/Lose results shown below
AEHR Roast Me summary
AEHR TEST SYSTEMS (AEHR). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinAEHR / S&P 159.06% / 15.20% |
LoseAEHR / S&P -15.21% / 15.00% |
LoseAEHR / S&P AEHR unavailable / 50.40% |
| 2026-Q11/3 |
WinAEHR / S&P 83.66% / -4.33% |
LoseAEHR / S&P -26.39% / 11.30% |
LoseAEHR / S&P -148.72% / 27.70% |
| 2025-Q40/3 |
LoseAEHR / S&P -32.95% / 2.65% |
LoseAEHR / S&P 4.96% / 9.00% |
LoseAEHR / S&P -140.00% / 13.40% |
| 2025-Q31/3 |
WinAEHR / S&P 132.87% / 8.12% |
LoseAEHR / S&P -3.23% / 4.61% |
LoseAEHR / S&P -122.45% / 13.45% |
| 2025-Q21/3 |
WinAEHR / S&P 77.37% / 10.94% |
LoseAEHR / S&P -10.95% / 4.83% |
LoseAEHR / S&P -111.61% / 10.63% |
| 2025-Q11/3 |
LoseAEHR / S&P -56.16% / -4.27% |
LoseAEHR / S&P -14.48% / 4.98% |
WinAEHR / S&P 50.00% / 10.57% |
| 2024-Q41/3 |
WinAEHR / S&P 29.42% / 2.41% |
LoseAEHR / S&P -37.77% / 5.25% |
LoseAEHR / S&P 5.63% / 6.15% |
| 2024-Q32/3 |
WinAEHR / S&P 15.04% / 5.89% |
LoseAEHR / S&P -21.63% / 5.89% |
WinAEHR / S&P 53.13% / 6.11% |
| 2024-Q21/3 |
LoseAEHR / S&P -9.92% / 4.28% |
LoseAEHR / S&P 1.94% / 5.38% |
WinAEHR / S&P 124.00% / 5.12% |
| 2024-Q11/3 |
LoseAEHR / S&P -53.26% / 10.56% |
WinAEHR / S&P 14.14% / 5.71% |
LoseAEHR / S&P 4.00% / 5.59% |
| 2023-Q42/3 |
LoseAEHR / S&P -41.95% / 11.69% |
WinAEHR / S&P 33.53% / 6.81% |
WinAEHR / S&P 61.36% / 7.78% |
| 2023-Q33/3 |
WinAEHR / S&P 10.79% / -3.27% |
WinAEHR / S&P 34.12% / 7.52% |
WinAEHR / S&P 88.24% / -5.03% |
| 2023-Q23/3 |
WinAEHR / S&P 32.98% / 8.74% |
WinAEHR / S&P 27.80% / 9.50% |
WinAEHR / S&P 47.06% / -8.57% |
| 2023-Q13/3 |
WinAEHR / S&P 54.33% / 7.50% |
WinAEHR / S&P 64.97% / 10.77% |
WinAEHR / S&P 212.50% / -15.69% |
| 2022-Q43/3 |
WinAEHR / S&P 42.55% / 7.56% |
WinAEHR / S&P 116.81% / 11.88% |
WinAEHR / S&P 780.00% / -17.99% |
| 2022-Q32/3 |
WinAEHR / S&P 88.00% / -4.88% |
WinAEHR / S&P 176.04% / 13.47% |
LoseAEHR / S&P AEHR unavailable / -1.41% |
| 2022-Q21/3 |
LoseAEHR / S&P -26.18% / -16.10% |
WinAEHR / S&P 206.20% / 13.71% |
LoseAEHR / S&P AEHR unavailable / 11.04% |
| 2022-Q11/3 |
LoseAEHR / S&P -57.98% / -4.60% |
WinAEHR / S&P 199.79% / 15.97% |
LoseAEHR / S&P AEHR unavailable / 42.23% |
| 2021-Q42/3 |
WinAEHR / S&P 77.14% / 11.03% |
WinAEHR / S&P 107.39% / 15.00% |
LoseAEHR / S&P AEHR unavailable / 96.40% |
| 2021-Q31/3 |
WinAEHR / S&P 394.57% / 0.58% |
LoseAEHR / S&P 7.80% / 10.77% |
LoseAEHR / S&P AEHR unavailable / 69.42% |
| 2021-Q21/3 |
WinAEHR / S&P 9.52% / 8.55% |
LoseAEHR / S&P -25.53% / 6.58% |
LoseAEHR / S&P AEHR unavailable / 51.81% |
| 2021-Q10/3 |
LoseAEHR / S&P -0.40% / 6.17% |
LoseAEHR / S&P -50.56% / -1.06% |
LoseAEHR / S&P -2400.00% / 7.39% |
| 2020-Q41/3 |
WinAEHR / S&P 82.01% / 12.15% |
LoseAEHR / S&P -40.47% / -3.72% |
LoseAEHR / S&P AEHR unavailable / -33.42% |
| 2020-Q30/3 |
LoseAEHR / S&P -29.08% / 8.93% |
LoseAEHR / S&P -14.09% / -2.04% |
LoseAEHR / S&P AEHR unavailable / -27.10% |
| 2020-Q21/3 |
LoseAEHR / S&P 17.37% / 20.54% |
WinAEHR / S&P 5.87% / -0.46% |
LoseAEHR / S&P AEHR unavailable / -27.11% |
| 2020-Q12/3 |
WinAEHR / S&P -16.50% / -19.60% |
WinAEHR / S&P 22.18% / 3.47% |
LoseAEHR / S&P AEHR unavailable / -14.75% |
| 2019-Q41/3 |
WinAEHR / S&P 11.73% / 9.07% |
LoseAEHR / S&P -9.88% / 5.36% |
LoseAEHR / S&P AEHR unavailable / 2.99% |
| 2019-Q31/3 |
WinAEHR / S&P 8.48% / 1.70% |
LoseAEHR / S&P -20.04% / 5.02% |
LoseAEHR / S&P AEHR unavailable / 0.21% |
| 2019-Q21/3 |
WinAEHR / S&P 19.57% / 4.30% |
LoseAEHR / S&P -28.76% / 6.64% |
LoseAEHR / S&P -1250.00% / 8.65% |
| 2019-Q10/3 |
LoseAEHR / S&P -2.13% / 13.65% |
LoseAEHR / S&P -27.22% / 8.12% |
LoseAEHR / S&P AEHR unavailable / 14.29% |
| 2018-Q40/3 |
LoseAEHR / S&P -36.49% / -13.52% |
LoseAEHR / S&P 4.35% / 9.05% |
LoseAEHR / S&P AEHR unavailable / 18.23% |
| 2018-Q31/3 |
LoseAEHR / S&P -5.53% / 7.71% |
WinAEHR / S&P 32.97% / 10.21% |
LoseAEHR / S&P AEHR unavailable / 19.06% |
| 2018-Q22/3 |
WinAEHR / S&P 4.44% / 3.43% |
WinAEHR / S&P 56.39% / 9.03% |
LoseAEHR / S&P AEHR unavailable / 14.46% |
| 2018-Q11/3 |
LoseAEHR / S&P -16.97% / -0.76% |
WinAEHR / S&P 110.13% / 7.68% |
LoseAEHR / S&P AEHR unavailable / 12.46% |
| 2017-Q41/3 |
LoseAEHR / S&P -33.74% / 6.64% |
WinAEHR / S&P 89.77% / 7.03% |
LoseAEHR / S&P AEHR unavailable / 13.82% |
| 2017-Q32/3 |
WinAEHR / S&P 9.07% / 4.48% |
WinAEHR / S&P 55.85% / 5.68% |
LoseAEHR / S&P AEHR unavailable / 17.57% |
| 2017-Q21/3 |
LoseAEHR / S&P -22.04% / 3.09% |
WinAEHR / S&P 30.32% / 4.83% |
LoseAEHR / S&P AEHR unavailable / 17.74% |
| 2017-Q11/3 |
WinAEHR / S&P 99.59% / 6.07% |
LoseAEHR / S&P -6.52% / 3.67% |
LoseAEHR / S&P AEHR unavailable / 13.32% |
| 2016-Q40/3 |
LoseAEHR / S&P -24.92% / 3.82% |
LoseAEHR / S&P -15.34% / 2.09% |
LoseAEHR / S&P AEHR unavailable / 7.05% |
| 2016-Q32/3 |
WinAEHR / S&P 99.38% / 3.85% |
WinAEHR / S&P 0.71% / 0.20% |
LoseAEHR / S&P AEHR unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | AEHR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 223.68% | 20.78% |
| Annualized return | 223.68% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | AEHR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 1045.52% | 83.14% |
| Annualized return | 62.85% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | AEHR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 3054.65% | 319.30% |
| Annualized return | 41.22% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COHU INC (COHU) | United States | $3.015B | -82.78 |
| ITRON, INC. (ITRI) | United States | $4.008B | 13.83 |
| ALLIENT INC (ALNT) | United States | $1.913B | 61.10 |
| FREQUENCY ELECTRONICS INC (FEIM) | United States | $0.952B | 236.51 |
| TRANSCAT INC (TRNS) | United States | $0.805B | 250.33 |
| INTEST CORP (INTT) | United States | $0.146B | 291.94 |
| ScanTech AI Systems Inc. (STAI) | United States | $0.069B | -2.69 |
| DATA I/O CORP (DAIO) | United States | $0.030B | -4.65 |
| Veralto Corp (VLTO) | United States | $23.619B | 22.32 |
| TERADYNE, INC (TER) | United States | $60.595B | 59.25 |